Furthermore, we found that i.t. administration of rIGF-1 as well as i.t. or i.p. treatment with EGCG alleviated the diabetes-induced pain-like behaviors, reduced neuroinflammation, averted the M1 microglia polarization, and recovered the microglial IGF-1 expression. Here, IGF1 is linked to diabetes mellitus.